VALIANT LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of VALIANT LABORATORIES have increased by 78.04% YoY .
The Earnings Per Share (EPS) of VALIANT LABORATORIES has increased by Negative YoY. |
||
VALIANT LABORATORIES Last 5 Annual Financial Results
[BOM: 543998|NSE : VALIANTLAB]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 |
|---|---|---|---|---|
| Revenues | ₹237 Cr | ₹133 Cr | ₹182 Cr | ₹334 Cr |
| Expenses | ₹232 Cr | ₹138 Cr | ₹190 Cr | ₹299 Cr |
| Operating Profit (Excl OI) | ₹5.97 Cr | ₹-4.69 Cr | ₹-8.41 Cr | ₹35 Cr |
| Other Income | ₹2.74 Cr | ₹5.45 Cr | ₹9.68 Cr | ₹4.89 Cr |
| Interest | ₹1.90 Cr | ₹0.18 Cr | ₹0.08 Cr | ₹0.25 Cr |
| Depreciation | ₹6.04 Cr | ₹2.09 Cr | ₹1.97 Cr | ₹1.56 Cr |
| Profit Before Tax | ₹0.77 Cr | ₹-1.51 Cr | ₹-0.77 Cr | ₹38 Cr |
| Profit After Tax | ₹-3.27 Cr | ₹-2.20 Cr | ₹0.32 Cr | ₹29 Cr |
| Consolidated Net Profit | ₹-3.27 Cr | ₹-2.20 Cr | ₹0.32 Cr | ₹29 Cr |
| Earnings Per Share (Rs) | ₹-0.60 | ₹-0.51 | ₹0.07 | ₹8.91 |
| PAT Margin (%) | -1.38 | -1.65 | 0.18 | 8.68 |
| ROE(%) | -1.20 | -0.93 | 0.19 | 28.86 |
| ROCE(%) | 0.75 | -0.40 | -0.29 | 24.01 |
| Total Debt/Equity(x) | 0.14 | 0.52 | 0.32 | 0.59 |
Key Financials |
||
| Market Cap | : | ₹ 687.7 Cr |
| Revenue (TTM) | : | ₹ 305.9 Cr |
| Net Profit(TTM) | : | ₹ 16.0 Cr |
| EPS (TTM) | : | ₹ 2.9 |
| P/E (TTM) | : | 43.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VALIANT LABORATORIES | -3.9% | 1.4% | 41% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -5.2% | 4.1% |
| DIVIS LABORATORIES | 4.9% | -0.5% | 43.8% |
| TORRENT PHARMACEUTICALS | -1.1% | -8.5% | 28.3% |
| CIPLA | 2.3% | -2.7% | -18.9% |
| DR REDDYS LABORATORIES | 7.8% | 11% | 1.2% |
| MANKIND PHARMA | 9.1% | 0.3% | 2.2% |
| LUPIN | 2.2% | -5.7% | 0.8% |
| ZYDUS LIFESCIENCES | 3.3% | -2.5% | 16.7% |
VALIANT LABORATORIES Revenues
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | 78.04 % |
| 5 Yr CAGR | -10.74 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹237 Cr | 78.04 | |
| Mar2025 | ₹133 Cr | -26.74 | |
| Mar2024 | ₹182 Cr | -45.48 | |
| Mar2023 | ₹334 Cr | - | |
VALIANT LABORATORIES Operating Profit
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Positive |
| 5 Yr CAGR | -44.59 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.97 Cr | Positive | |
| Mar2025 | ₹-4.69 Cr | Negative | |
| Mar2024 | ₹-8.41 Cr | Negative | |
| Mar2023 | ₹35 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | -37.94 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 2.51% | Positive | |
| Mar2025 | -3.52% | Negative | |
| Mar2024 | -4.62% | Negative | |
| Mar2023 | 10.5% | - | |
VALIANT LABORATORIES Profit After Tax
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.27 Cr | Negative | |
| Mar2025 | ₹-2.20 Cr | Negative | |
| Mar2024 | ₹0.32 Cr | -98.90 | |
| Mar2023 | ₹29 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | -1.38 % | Negative | |
| Mar2025 | -1.65 % | Negative | |
| Mar2024 | 0.18 % | -97.93 | |
| Mar2023 | 8.68 % | - | |
VALIANT LABORATORIES Earnings Per Share (EPS)
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹-0.60 | Negative | |
| Mar2025 | ₹-0.51 | Negative | |
| Mar2024 | ₹0.07 | -99.21 | |
| Mar2023 | ₹8.91 | - | |
VALIANT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 543998|NSE : VALIANTLAB]
| Y-o-Y | Positive |
| 5 Yr CAGR | -68.51 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 0.75% | Positive | |
| Mar2025 | -0.4% | Negative | |
| Mar2024 | -0.29% | Negative | |
| Mar2023 | 24.01% | - | |
VALIANT LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹126.7 |
| Current MarketCap | : | ₹ 687.7 Cr |
| Updated EOD on | : | Oct 28,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -3.9% |
1.4% |
41% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
VALIANT LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about VALIANT LABORATORIES Financials
How the annual revenues of VALIANT LABORATORIES have changed ?
The Revenues of VALIANT LABORATORIES have increased by 78.04% YoY .
How the Earnings per Share (EPS) of VALIANT LABORATORIES have changed?
The Earnings Per Share (EPS) of VALIANT LABORATORIES has increased by Negative YoY .
Check out Intrinsic Value of Peers of VALIANT LABORATORIES
Compare Stock Analytics of Peers of VALIANT LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
